Skip to Content

Ilaris Prices, Coupons and Patient Assistance Programs

Ilaris (canakinumab) is a member of the interleukin inhibitors drug class and is commonly used for Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Familial Mediterranean Fever, and others.

Ilaris Prices

This Ilaris price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Ilaris subcutaneous powder for injection 150 mg is around $16,770 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Subcutaneous Powder For Injection

150 mg Ilaris subcutaneous powder for injection
from $16,769.93 for 1 powder for injection
Quantity Per unit Price
1 $16,769.93 $16,769.93

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Subcutaneous Solution

150 mg/mL Ilaris subcutaneous solution
from $16,769.93 for 1 milliliter(s)
Quantity Per unit Price
1 milliliter(s) $16,769.93 $16,769.93

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Ilaris Coupons and Rebates

Ilaris offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Ilaris Co-pay Assistance Program: Eligible commercially insured patients may pay no more than $30 per prescription; for additional information contact the program at 866-972-8315.

Applies to:Ilaris
Number of uses:Per prescription until program expires

Patient Assistance Programs for Ilaris

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Ilaris Patient Support Program

Elligibility requirements:

  1. Determined case by case
  2. Not disclosed
  3. FDA-approved diagnosis
  4. Must be residing in the US or US territory
  5. Eligibility determined on a case-by-case basis.

Applicable drugs:

  • Ilaris (canakinumab) Injection; Subcutaneous

Provider: Novartis Patient Assistance Foundation, Inc.

Elligibility requirements:

  1. Contact program for details.
  2. At or below 600% of FPL
  3. Not specified
  4. The patient must reside in the US, Puerto Rico or the USVI.
  5. For Focalin XR, Clozaril, and Ritalin LA, Clozarila pharmacy card will be issued. All other medication will be shipped directly to the patient, unless otherwise noted. *Additional products may be available. Please contact the program for a complete product listing. www.pap.novartis.com

Applicable drugs:

  • Ilaris (canakinumab)

Provider: HealthWell Foundation Copay Program

Elligibility requirements:

  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Ilaris (canakinumab)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Ilaris (canakinumab)
Hide